期刊文献+

人CD154基因绿色荧光真核表达载体的构建

Construction of Human CD154 Gene Eukaryotic Green Fluorescent Protein Expression Vector pEGFP-N3-CD154
下载PDF
导出
摘要 目的构建携人CD154基因的重组真核绿色荧光蛋白表达载体pEGFP N3-CD154。方法体外PHA激活人外周血单个核细胞,提取总RNA,用RT-PCR技术扩增人CD154 cDNA全长开放阅读框序列,T-A克隆至pGEM_TEasy载体,再定向克隆至增强型绿色荧光蛋白载体pEGFP-N3,重组质粒pEGFP_N3_CD154用限制性内切酶酶切鉴定,通用鉴定引物PCR扩增鉴定,并进行DNA序列分析。结果多种鉴定方法证实了重组载体中的CD154基因序列与已知的序列一致。结论成功构建了携带人CD154基因的重组的增强型绿色荧光蛋白表达载体pEGFP-N3-CD154,为进一步研究人CD154基因转染细胞在肿瘤免疫治疗中的生物学意义提供初步的实验基础。 Objective To construct recombined eukaryotic green fluorescent protein expression vector pEGFP-N3-CD154.Methods Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) which were activated with PHA in vitro. The amplification of CD154 cDNA open reading frame sequence was conducted using PT-PCR. The fragment of CD154 cDNA was cloned into pGEM T Easy vector, and then cloned directly into pEGFP-N3. The recombinant plasmid pEGFP-N3-CD154 was identified by restriction enzyme, PCR,and DNA sequence analyzing technique. Results CD154 gene sequence in the recombined vector was identical with the GenBank (NM-000074). Conclusion The recombined eukaryotic green fluorescent protein expression vector pEGFP-N3-CD154 can be obtained. The results provide basis for the further studies of the biological significance of human CD154 gene transfected cell in tumor immunotherapy.
出处 《河南职工医学院学报》 2006年第4期258-262,共5页 Journal of Henan Medical College For Staff and Workers
基金 河南省卫生厅创新人才项目(20043008)
关键词 CD154 增强型绿色荧光蛋白 DNA序列分析 CD154 enhanced green fluorescent protein(EGFP) DNA sequence analyzing
  • 相关文献

参考文献8

  • 1Alexandroff AB,Jackson AM,Paterson T,et al.Role for CD40-CD40 ligand interactions in the immune response to solid tumours[J].Mol Immunol,2000,37 (9):515 -526.
  • 2Schoenberger SP,Toes REM,van der Vorrt et al.T-cell help for cytotoxic T lymphocytes if mediated by CD40-CD40L interactions[J].Nature,1998,393:480-483.
  • 3Bennett SRM,Carbone FR,Karamalis F,et al.Help for cytotoxic-T-cell responses is mediated by CD40 signalling[J].Nature,1998,393:478-480.
  • 4Schonbec U,Mach F,Libby P.CD154 (CD40 ligand)[J].Int J Biochem Cell Biol,2000,32 (7):687-693.
  • 5Toes REM,Schoenberger SP,van der Vorrt EIH,et al.CD40-CD40 Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity[J].Semin immunol,1998,10:443-448.
  • 6Van Mierlo GJ,den Borer AT,Medema JP,et al.CD40 stimulation leads to effective therapy of CD40 (-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity[J].Proc Natl Acad Sci USA,2002,99(8):5 561-5 566.
  • 7Schmitz V,Barajas M,Wang L,et al.Adenovirus-mediated CD 40 ligand gene therapy in a rat model o orthotpic hepatocellular carcinoma[J].Hepatology,2001,34 (1):72-81.
  • 8Wierda WA,Cantwell MJ,Woods SJ,et al.CD40-ligand (CD154)gene therapy for chronic lymphocytic leukemia[J].Blood,2000,96 (9):2917-2 924.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部